Titan Pharmaceuticals — Company Overview, News & Financial Data

Titan Pharmaceuticals (NASDAQ:TTNP) focuses on the development of therapeutics for the treatment of chronic diseases, leveraging its proprietary long-term drug delivery platform, ProNeura. This innovative approach aims to improve the treatment of conditions like opioid addiction and chronic pain by ensuring consistent, long-term medication levels in the body, potentially reducing the need for frequent dosing. The company's key project, Probuphine, is an implant that delivers buprenorphine for the treatment of opioid addiction, marking a significant step towards addressing this growing epidemic. Titan Pharmaceuticals is dedicated to expanding its portfolio through the development of new therapies and partnerships, with the objective of enhancing patient care and addressing unmet medical needs in chronic disease management.